Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Korro Bio, Inc. - Common Stock (NQ: KRRO ) 33.00 -1.51 (-4.38%) Streaming Delayed Price Updated: 1:02 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Korro Bio, Inc. - Common Stock 3 Stocks That Could Rise on European Bank Interest Rate Cuts September 22, 2024 The European Central Bank cut interest rates for the second time in about three months prior the FOMC's interest rate announcement, European stocks may benefit. Via MarketBeat Topics Economy Exposures Interest Rates Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks September 19, 2024 This strategic play will take time to pay off, but it could keep growth going. Via The Motley Fool Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications September 18, 2024 Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (NYSE:NVO) to advance the ... Via Benzinga Gold Edges Lower; US Homebuilder Sentiment Rises For September September 17, 2024 Via Benzinga Crude Oil Gains Over 1%; US Business Inventories Increase In July September 17, 2024 Via Benzinga Exposures Fossil Fuels Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating August 14, 2024 William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1... Via Benzinga KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024 August 13, 2024 KRRO stock results show that Korro Bio missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023 June 25, 2024 KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024 May 14, 2024 KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday February 13, 2024 U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Why Newly Listed Korro Bio Shares Are Gaining Today December 04, 2023 H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat various diseases. Via Benzinga These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024? December 02, 2023 These stocks are coming off a banner month, but what about the road ahead? Via The Motley Fool Chegg, Perdoceo Education And Other Big Stocks Moving Lower On Monday November 20, 2023 U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's After-Market Session November 07, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.